Biocon launches bone therapy biosimilars Bosaya, Aukelso in US market

Bosaya, a biosimilar to Prolia, and Aukelso, a biosimilar to Xgeva, are now available by prescription across the country through specialty pharmacies and healthcare providers, said the company.

Leave a Reply

Your email address will not be published. Required fields are marked *